Generic drugs produced in India are increasingly being accepted worldwide, with leading companies such as Ranbaxy Cipla and Dr Reddy's paving the way for others. Indian companies have increasingly taken on outsourced manufacturing for foreign clients, in addition to marketing pharmaceuticals themselves. There are also new drug development programmes by Indian companies, with eventual international market launches.
supply chain www.pharma-mag.com hub hyderabad india’S pharmaCeutiCal Capital The market for pharmaceuticals in India has a strong potential for increased growth, from 2008 right through to 2023. With
Pages to are hidden for
"HUB HYDERABAD INDIA S PHARMACEUTICAL CAPITAL"Please download to view full document